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Introduction 
 Some mushrooms are known to have strong 
antioxidant capacity [1]. There is an accepted 
relationship between the physiopathology of several 
chronic diseases and oxidative stress. Therefore, the use 
of foods such as those mushrooms with antioxidant 
capacity, as phytochemical protectors, may be relevant 
for the prevention of oxidative stress related diseases 
such as cancer. Additionally, mushrooms have been 
described as a source of potential antitumour 
molecules, making them attractive candidates for drug 
discovery [2,3]. However, there are no such studies on 
the Portuguese wild mushroom Lepista inversa.  
Materials and methods 
Lepista inversa (Scop.: Fr.) Pat. (Tricholomataceae) was 
collected in Bragança (Northeast Portugal), in autumn 
2008. Taxonomic identification was made according to 
different authors and representative voucher specimens 
were deposited at the herbarium of Escola Superior 
Agrária of Instituto Politécnico de Bragança. This is a 
saprotrophic and edible species. The samples were 
lyophilised and reduced to a fine dried powder.  
The extracts studied were methanolic, ethanolic and 
polissacharidic.   
For the antioxidant activity the following assays were 
used: evaluation of DPPH (2,2-diphenyl-1-picrylhydrazyl) 
radical scavenging capacity, reducing power and 
inhibition of lipid peroxidation (LPO) measured in 
liposome solutions [4].  
For the analysis of extract-induced cell growth 
inhibition the SRB (sulforhodamine B) assay [5] was 
used, following treatment of four tumour cell lines (lung, 
breast, colon and gastric cancer) with the different 
extracts. 
 
The polysaccharidic extract presented the strongest 
antioxidant capacity (EC50 < 1.8 ± 0.1 mg/ml). 
Regarding the capacity to inhibit the growth of human 
tumour cell lines, the methanolic extract was the most 
effective, presenting the lowest GI50 values (GI50 < 
134.8 ± 10.9 µg/ml).  
Results and discussion 
 Extracts   (%) 
Phenolics 
(mg GAE/g) 
DPPH scav. 
activity 
Reducing 
power 
LPO 
inhibition 
 Methanolic 39.0  1.9  3.6  0.1  10.6  1.1 2.9  0.1 1.1  0.1  
 Ethanolic 4.6  0.5 10.8  0.7 9.3  0.5 1.4  0.1 1.5  1.1  
 Polysaccharidic 32.2  3.1 - 1.8  0.1 0.7  0.0 0.9  0.1 
Table 1. Antioxidant activity of Lepista inversa extracts.  
Results are expressed as EC50 (concentrations of extract in mg/ml that cause 50% of antioxidant activity, unless for 
reducing power that is 0.5 of absorbance), and show means  SEM of 3 independent observations.   
  Extracts 
NCI-H460 
(lung cancer) 
MCF-7 
(breast cancer) 
HCT-15 
 (colon cancer) 
AGS 
(gastric cancer) 
  
 Methanolic 36.3  5.1 45.2  3.1 39.7  4.6 67.4  5.5   
 Ethanolic 118.3  2.5 79.1  11.8 42.3  4.5 58.5  3.3 
 Polysaccharidic 155.0  3.5 137.4  1.3 77.4  5.5 99.9  7.8 
Table 2. Effects of Lepista inversa extracts on the growth of human tumour cell lines.  
Results are expressed as GI50 (concentrations of extract in µg/ml that cause 50% of growth inhibition of human 
tumour cell lines), and show means  SEM of 3-6 independent observations performed in duplicate.g 
In summary, polysaccharidic extract of Lepista inversa 
was the most potent as antioxidant, while the 
methanolic extract was the most potent as inhibitor of 
growth of human tumour cell lines. This interesting 
growth inhibitory activity proves that this mushroom, 
particularly the ethanolic extract is a promising source 
of bioactive compounds. As far as we know, there are 
no reports of growth inhibitory activity of the studied 
species against lung, colon and gastric human cancer 
cells. Future work will elucidate the mechanism of 
action of these extracts leading to the observed cell 
growth inhibition. 
Conclusions 
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Objective 
The aim of the present work was to study extracts 
obtained from the wild mushroom Lepista inversa for 
the in vitro antioxidant activity and growth inhibitory 
activity in human tumour cell lines.  
 
